CNE100000GY2
CNE100000GY2
ANKEBIO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 14.25B EUR | 13.12B EUR | 15.79B EUR |
Enterprise Value | 12.87B EUR | 12.93B EUR | 15.64B EUR |
Valuation Multiples | |||
Trailing P/E | 20.31x | 19.47x | 21.99x |
Forward P/E | 12.01x | -- | -- |
Price to Sales | 5.81x | 5.36x | 6.27x |
Price to Book | 3.3x | 3.08x | 3.33x |
EV/Revenue | 5.25x | 5.29x | 6.21x |
EV/EBITDA | 14.63x | 16.7x | 18.77x |
Price to FCF (P/FCF) | 34.34x | 22.87x | 24.86x |
EV/FCF | 31.02x | 22.55x | 24.63x |
FCF Yield | 2.91% | 4.37% | 4.02% |